Business & Tech
Report: Parent Company Shakes Up Leadership At Gaithersburg Biotech Giant
MedImmune executive Bahija Jallal will replace current MedImmune President Peter Greenleaf, Washington Business Journal reports.
Gaithersburg biotech giant MedImmune is under new leadership thanks to a shakeup by its parent company, AstraZeneca, according to a report by Washington Business Journal.
MedImmune executive Bahija Jallal will replace current MedImmune President Peter Greenleaf as chief of the Gaithersburg drugmaker, according to the report. Greenleaf — MedImmune's president since 2010 — will lead AstraZeneca's Latin American business beginning in March.
More changes for the biotech firm are in the works, but there has been "no announcement yet on other job changes or potential layoffs," according to the report.
Interested in local real estate?Subscribe to Patch's new newsletter to be the first to know about open houses, new listings and more.
Get more local news delivered straight to your inbox. Sign up for free Patch newsletters and alerts.
We’ve removed the ability to reply as we work to make improvements. Learn more here
